Impaired renal function gout: its association with hypertensive vascular disease and intrinsic renal disease.
Inulin clearance was measured in 624 patients with gout, and para-aminohippuric acid (PAH) clearance in 359; Group I consisted of 397 patients with uncomplicated gout; Group II, 191 patients with hypertension and/or ischemic heart disease; and Group III, 36 patients with chronic renal disease. Mean inulin clearance was normal in Group I, slightly depressed in Group II and more markedly decreased in Group III. There was some reduction in PAH clearance in all groups, but not in the very young patients with no complications. A disproportionate reduction in PAH clearance was noted in Groups II and III, particularly in the older patients with longer duration of gout. Uncomplicated gout, except in rare cases of fulminating gout, does not lead to decreased renal hemodynamics. An increased incidence of tophi correlates with decreased renal function, but incidence of renal calculi does not. Renal insufficiency when seen in patients with gout usually correlates with coexistence of hypertension, ischemic heart disease, or primary preexistent renal insufficiency.
D000293:Adolescent; D000328:Adult; D000368:Aged; D000375:Aging; D003327:Coronary Disease / Q000150:complications; D006073:Gout / Q000150:complications / Q000378:metabolism / Q000503:physiopathology*; D006801:Humans; D006973:Hypertension / Q000150:complications* / Q000378:metabolism; D007444:Inulin / Q000378:metabolism; D007668:Kidney / Q000503:physiopathology*; D007669:Kidney Calculi / Q000378:metabolism; D007674:Kidney Diseases / Q000150:complications*; D007676:Kidney Failure, Chronic / Q000378:metabolism; D008875:Middle Aged; D010130:p-Aminohippuric Acid / Q000378:metabolism
D007444:Inulin; D010130:p-Aminohippuric Acid